Related Experiment Video

Updated: Oct 4, 2025

Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches
05:56

Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches

Published on: October 13, 2022

1.5K

Post-Translational Modification of Cav1.2 and its Role in Neurodegenerative Diseases

Yun Li1, Hong Yang1, Tianhan He1

  • 1Jiangsu Province Key Laboratory of Anesthesiology, Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, NMPA Key Laboratory for Research and Evaluation of Narcotic and Psychotropic Drugs, School of Anesthesiology, Xuzhou Medical University, Xuzhou, China.

Frontiers in Pharmacology
|February 3, 2022
PubMed

Insights

Calcium channel Cav1.2 is crucial for brain function and implicated in neurodegenerative diseases. Modulating Cav1.2 activity offers potential therapeutic strategies for conditions like Parkinson's and Alzheimer's disease.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • The Cav1.2 calcium channel is vital for neuronal function, impacting learning, memory, and development.
  • Disrupted intracellular calcium homeostasis due to abnormal Cav1.2 activity is linked to neurodegenerative diseases.
  • Post-translational modifications of Cav1.2 are associated with neurodegenerative disease pathogenesis.

Purpose of the Study:

  • To explore the role of Cav1.2 channel activity in neurodegenerative diseases.
  • To understand the mechanisms regulating Cav1.2 channel function.
  • To evaluate the therapeutic potential of targeting Cav1.2 channels.

Main Methods:

  • Review of existing literature on Cav1.2 channel function and neurodegeneration.
  • Analysis of studies on post-translational modifications of Cav1.2.
  • Examination of repurposed dihydropyridine (DHP) drugs in neurodegenerative disease models.

Main Results:

  • Cav1.2 dysfunction contributes to disrupted calcium homeostasis in neurodegenerative conditions.
  • Dihydropyridines (DHPs) show protective effects in Parkinson's (PD) and Alzheimer's (AD) models.
  • Mechanisms of Cav1.2 regulation require further elucidation.

Conclusions:

  • Targeting Cav1.2 channels presents a promising therapeutic avenue for neurodegenerative diseases.
  • Improved drug delivery and selectivity are necessary for effective DHP-based therapies.
  • Further research into Cav1.2 modulation could yield novel treatment strategies.
Keywords:
Cav1.2PTM (post-translational modification)neurodegenerative diseasephosphorylationubiquitination

More Related Videos

A High-content Assay for Monitoring AMPA Receptor Trafficking10:34

A High-content Assay for Monitoring AMPA Receptor Trafficking

Published on: January 28, 2019

7.8K
Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis08:59

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

2.8K

Related Concept Videos

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
499
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.9K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
7.7K
RNA Editing02:23

RNA Editing

RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.2K
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
12.8K